Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Enanta Pharmaceuticals (ENTA) over the last 9 years, with Q3 2025 value amounting to 7.7.

  • Enanta Pharmaceuticals' Interest Coverage Ratio rose 3340.83% to 7.7 in Q3 2025 from the same period last year, while for Sep 2025 it was 11.11, marking a year-over-year increase of 10.6%. This contributed to the annual value of 11.11 for FY2025, which is 10.6% up from last year.
  • As of Q3 2025, Enanta Pharmaceuticals' Interest Coverage Ratio stood at 7.7, which was up 3340.83% from 11.68 recorded in Q2 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Interest Coverage Ratio ranged from a high of 7.7 in Q3 2025 and a low of 18.38 during Q2 2023
  • Over the past 3 years, Enanta Pharmaceuticals' median Interest Coverage Ratio value was 11.62 (recorded in 2024), while the average stood at 11.87.
  • The largest annual percentage gain for Enanta Pharmaceuticals' Interest Coverage Ratio in the last 5 years was 4413.84% (2024), contrasted with its biggest fall of 1835.76% (2024).
  • Enanta Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 10.14 in 2023, then fell by 18.36% to 12.0 in 2024, then soared by 35.81% to 7.7 in 2025.
  • Its Interest Coverage Ratio was 7.7 in Q3 2025, compared to 11.68 in Q2 2025 and 14.31 in Q1 2025.